<DOC>
	<DOCNO>NCT01869699</DOCNO>
	<brief_summary>The purpose study compare effect intravenous acetaminophen placebo body temperature hemodynamic ( heart rate blood pressure ) responses febrile critically ill adult patient . There limited data explain variable unpredictable antipyretic hemodynamic response acetaminophen febrile ICU patient . The complex pathophysiology critically ill patient , co-morbid condition , effect multiple pharmacologic non-pharmacologic care intervention , and/or potential interference absorption enteral rectal formulation may relate variation antipyretic response acetaminophen . It necessary clinician well understand therapy response potential adverse effect commonly administer medication , especially recently available IV formulation , critically ill patient . Further research antipyretic response acetaminophen critically ill patient warrant inform evidence-based practice guideline fever management . Further randomize , placebo-controlled study hemodynamic response IV acetaminophen also warrant . Primary Hypothesis : There significant reduction time-weighted average core body temperature 4 hour administration IV acetaminophen compare placebo febrile critically ill patient . Secondary Hypotheses : 1 . There significant reduction time-weighted average heart rate 4 hour administration IV acetaminophen compare placebo febrile critically ill patient . 2 . There significant reduction time-weighted mean arterial pressure 4 hour administration IV acetaminophen compare placebo febrile critically ill patient . Adult patient fever ( ≥ 38.3ºCentigrade/101ºFarenheit ) intensive care unit screen eligibility enrol informed consent . Patients randomize receive IV acetaminophen 1 gram normal saline 100 mLs . Body temperature , heart rate , blood pressure measure baseline 4 hour post study drug administration .</brief_summary>
	<brief_title>Effects Intravenous Acetaminophen Body Temperature Hemodynamic Responses Febrile Critically Ill Adults</brief_title>
	<detailed_description>Adult patient fever ( ≥ 38.3ºCentigrade ( C ) /101ºFarenheit ( F ) ) intensive care unit screen eligibility approach informed consent . Enrolled patient stratify base lead etiology fever : either neurologic injury infection randomize receive IV acetaminophen 1 gram normal saline 100 milliliter ( mLs ) . Core body temperature measure use zero-heat flow thermometry system ( non-invasive , small disk forehead ) . Patients monitor data collect 4-hour post study drug administration period . A rescue protocol implemented temperature reach ≥ 40 ºC study period include notification primary team provider nurse pharmacist contact inform provider study group ( acetaminophen placebo ) . The provider decide whether order antipyretic medication physical cooling intervention time .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>18 year age old Patient intensive care unit Weight great equal 50 kg Fever : core body temperature great equal 38.3 degree Celsius Clinically stable : active resuscitation fluid , blood product , dose increase vasoactive medication within 1 hour study drug administration Acetaminophen hypersensitivity Acute liver failure acute liver injury Heat stroke , malignant hyperthermia , neuroleptic malignant syndrome Therapeutic cooling , physical cooling , extracorporeal blood circuit therapy Administration acetaminophencontaining medication , nonsteroidal antiinflammatory drug , aspirin great 81 mg within specify time per drug prior fever presentation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Fever</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Critical Care</keyword>
	<keyword>ICU</keyword>
	<keyword>Febrile</keyword>
</DOC>